Sinocare Inc
SZSE:300298

Watchlist Manager
Sinocare Inc Logo
Sinocare Inc
SZSE:300298
Watchlist
Price: 23.29 CNY -5.56% Market Closed
Market Cap: 12.9B CNY
Have any thoughts about
Sinocare Inc?
Write Note

Intrinsic Value

The intrinsic value of one Sinocare Inc stock under the Base Case scenario is 36.62 CNY. Compared to the current market price of 23.29 CNY, Sinocare Inc is Undervalued by 36%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
36.62 CNY
Undervaluation 36%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Sinocare Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Sinocare Inc cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Sinocare Inc?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Sinocare Inc

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Sinocare Inc

Provide an overview of the primary business activities
of Sinocare Inc.

What unique competitive advantages
does Sinocare Inc hold over its rivals?

What risks and challenges
does Sinocare Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Sinocare Inc.

Provide P/S
for Sinocare Inc.

Provide P/E
for Sinocare Inc.

Provide P/OCF
for Sinocare Inc.

Provide P/FCFE
for Sinocare Inc.

Provide P/B
for Sinocare Inc.

Provide EV/S
for Sinocare Inc.

Provide EV/GP
for Sinocare Inc.

Provide EV/EBITDA
for Sinocare Inc.

Provide EV/EBIT
for Sinocare Inc.

Provide EV/OCF
for Sinocare Inc.

Provide EV/FCFF
for Sinocare Inc.

Provide EV/IC
for Sinocare Inc.

Show me price targets
for Sinocare Inc made by professional analysts.

What are the Revenue projections
for Sinocare Inc?

How accurate were the past Revenue estimates
for Sinocare Inc?

What are the Net Income projections
for Sinocare Inc?

How accurate were the past Net Income estimates
for Sinocare Inc?

What are the EPS projections
for Sinocare Inc?

How accurate were the past EPS estimates
for Sinocare Inc?

What are the EBIT projections
for Sinocare Inc?

How accurate were the past EBIT estimates
for Sinocare Inc?

Compare the revenue forecasts
for Sinocare Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Sinocare Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Sinocare Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Sinocare Inc compared to its peers.

Compare the P/E ratios
of Sinocare Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Sinocare Inc with its peers.

Analyze the financial leverage
of Sinocare Inc compared to its main competitors.

Show all profitability ratios
for Sinocare Inc.

Provide ROE
for Sinocare Inc.

Provide ROA
for Sinocare Inc.

Provide ROIC
for Sinocare Inc.

Provide ROCE
for Sinocare Inc.

Provide Gross Margin
for Sinocare Inc.

Provide Operating Margin
for Sinocare Inc.

Provide Net Margin
for Sinocare Inc.

Provide FCF Margin
for Sinocare Inc.

Show all solvency ratios
for Sinocare Inc.

Provide D/E Ratio
for Sinocare Inc.

Provide D/A Ratio
for Sinocare Inc.

Provide Interest Coverage Ratio
for Sinocare Inc.

Provide Altman Z-Score Ratio
for Sinocare Inc.

Provide Quick Ratio
for Sinocare Inc.

Provide Current Ratio
for Sinocare Inc.

Provide Cash Ratio
for Sinocare Inc.

What is the historical Revenue growth
over the last 5 years for Sinocare Inc?

What is the historical Net Income growth
over the last 5 years for Sinocare Inc?

What is the current Free Cash Flow
of Sinocare Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Sinocare Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Sinocare Inc

Current Assets 2.1B
Cash & Short-Term Investments 669.6m
Receivables 701.3m
Other Current Assets 732m
Non-Current Assets 3.8B
Long-Term Investments 358.8m
PP&E 1.9B
Intangibles 1.4B
Other Non-Current Assets 138.4m
Current Liabilities 1.5B
Accounts Payable 298.2m
Accrued Liabilities 255.5m
Short-Term Debt 9.5m
Other Current Liabilities 948.3m
Non-Current Liabilities 1.2B
Long-Term Debt 567.1m
Other Non-Current Liabilities 655.6m
Efficiency

Earnings Waterfall
Sinocare Inc

Revenue
4.2B CNY
Cost of Revenue
-1.9B CNY
Gross Profit
2.3B CNY
Operating Expenses
-1.9B CNY
Operating Income
378m CNY
Other Expenses
-71.5m CNY
Net Income
306.5m CNY

Free Cash Flow Analysis
Sinocare Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Sinocare Inc's profitability score is 57/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Years Revenue Growth
Positive Free Cash Flow
Positive Revenue Growth Forecast
57/100
Profitability
Score

Sinocare Inc's profitability score is 57/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Sinocare Inc's solvency score is 68/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Negative Net Debt
68/100
Solvency
Score

Sinocare Inc's solvency score is 68/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Sinocare Inc

Wall Street analysts forecast Sinocare Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Sinocare Inc is 32.28 CNY with a low forecast of 29.29 CNY and a high forecast of 36.02 CNY.

Lowest
Price Target
29.29 CNY
26% Upside
Average
Price Target
32.28 CNY
39% Upside
Highest
Price Target
36.02 CNY
55% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Sinocare Inc?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Sinocare Inc is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Sinocare Inc Logo
Sinocare Inc

Country

China

Industry

Health Care

Market Cap

13.1B CNY

Dividend Yield

0.86%

Description

Sinocare, Inc. engages in the research, development, manufacture, and commercialization of biosensor-based blood glucose monitoring systems. The company is headquartered in Changsha, Hunan and currently employs 3,534 full-time employees. The company went IPO on 2012-03-19. The firm mainly provides micro blood instant blood sugar monitoring systems including blood sugar testing instruments and related blood sugar testing strips, as well as blood sugar testing systems and mobile blood sugar instruments, among others. The firm also provides diabetes management information systems. The company distributes its products within domestic market and to overseas markets under the brand name of SANNUO.

Contact

HUNAN
Changsha
No. 265 Guyuan Road, High-Tech Industrial Development Zone
+8673189935529
www.sinocare.com

IPO

2012-03-19

Employees

3 534

Officers

Chairman & GM
Mr. Shao Bo Li
Deputy General Manager
Mr. Jianwen Cai
Chairman of the Supervisory Board & Assistant to the GM
Mr. Baishen Ouyang
Supervisor & Supply Chain Director
Mr. Chungeng Chen

See Also

Discover More
What is the Intrinsic Value of one Sinocare Inc stock?

The intrinsic value of one Sinocare Inc stock under the Base Case scenario is 36.62 CNY.

Is Sinocare Inc stock undervalued or overvalued?

Compared to the current market price of 23.29 CNY, Sinocare Inc is Undervalued by 36%.

Back to Top